Skip to main content
Erschienen in: Reactions Weekly 1/2016

01.11.2016 | Case report

Fenretinide/isotretinoin

Premature physeal closure: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Steineck A, et al. Premature physeal closure following 13-cis-retinoic acid and prolonged fenretinide administration in neuroblastoma. Pediatric Blood and Cancer 63: 2050-2053, No. 11, Nov 2016 - USACrossRefPubMed Steineck A, et al. Premature physeal closure following 13-cis-retinoic acid and prolonged fenretinide administration in neuroblastoma. Pediatric Blood and Cancer 63: 2050-2053, No. 11, Nov 2016 - USACrossRefPubMed
Metadaten
Titel
Fenretinide/isotretinoin
Premature physeal closure: 2 case reports
Publikationsdatum
01.11.2016
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-016-22808-z

Weitere Artikel der Ausgabe 1/2016

Reactions Weekly 1/2016 Zur Ausgabe

Case report

Stanozolol abuse

Case report

Trabectedin

Case report

Ocriplasmin

Case report

Carfilzomib

Case report

Nebivolol